Foresite Capital Management V, LLC

Position in PHVS — Pharvaris N.V.

CIK 1792206 WEST HOLLYWOOD, CA

Position in PHVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,966,030

+$17,481,999 QoQ

Shares Held

664,142

+242.1% QoQ

Ownership

0.946%

of shares outstanding

% of Portfolio

6.34%

of 13F equity value

Holder Rank

#24

of 124 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Foresite Capital Management V, LLC holds $336,610,422 across 8 Biotechnology names. PHVS ranks #4 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALMS	Alumis Inc.	5,896,995	$165,941,439
2	CGON	CG Oncology, Inc.	1,079,050	$76,666,502
3	IRON	Disc Medicine, Inc.	374,069	$27,359,406
4	PHVS	Pharvaris N.V. This page	664,142	$22,966,030
5	EIKN	Eikon Therapeutics, Inc.	1,318,983	$17,212,728
6	ODTX	Odyssey Therapeutics, Inc.	713,105	$13,342,194
7	LYEL	Lyell Immunopharma, Inc.	476,386	$6,693,223
8	NRIX	Nurix Therapeutics, Inc.	265,000	$6,428,900

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,966,030	664,142	+242.1%	Shares	Sole	2026-08-14
2026-03-31	$5,484,031	194,125	+485.7%	Shares	Sole	2026-05-15
2023-09-30	$691,673	33,142	-2.9%	Shares	Sole	2023-11-13
2023-06-30	$516,909	34,142	0.0%	Shares	Sole	2023-08-11
2023-03-31	$275,013	34,142	0.0%	Shares	Sole	2023-05-12
2022-12-31	$384,097	34,142	0.0%	Shares	Sole	2023-02-13
2022-09-30	$261,869	34,142	0.0%	Shares	Sole	2022-11-14
2022-06-30	$754,538	34,142	0.0%	Shares	Sole	2022-08-12
2022-03-31	$619,165	34,142	0.0%	Shares	Sole	2022-05-13
2021-12-31	$491,303	34,142	-90.6%	Shares	Sole	2022-02-11
2021-09-30	$6,456,237	364,142	0.0%	Shares	Sole	2021-11-12
2021-06-30	$6,783,965	364,142	-45.2%	Shares	Sole	2021-08-16
2021-03-31	$18,582,693	664,142	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.